Core Laboratories Inc (CLB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2021 | 12-2020 | 09-2020 | 06-2020 | 03-2020 | |
| Sales | 108,383 | 113,749 | 105,382 | 115,736 | 152,400 |
| Cost of Goods | 84,150 | 87,918 | 81,038 | 90,680 | 115,131 |
| Gross Profit | 24,233 | 25,831 | 24,344 | 25,056 | 37,269 |
| Operating Expenses | 12,761 | 3,345 | 13,051 | 28,303 | 146,373 |
| Operating Income | 11,622 | 23,404 | 11,331 | -2,567 | -108,973 |
| Interest Expense | 1,363 | 2,920 | 4,672 | 3,369 | 3,411 |
| Pre-tax Income | 10,259 | 20,484 | 6,659 | -5,936 | -112,384 |
| Income Tax | 2,052 | 6,540 | 3,663 | -261 | -4,046 |
| Net Income Continuous | 8,207 | 13,944 | 2,996 | -5,675 | -108,338 |
| Minority Interests | 102 | -17 | 33 | 41 | 83 |
| Net Income | $8,105 | $13,537 | $2,963 | $-5,716 | $-108,421 |
| EPS Basic Total Ops | 0.18 | 0.30 | 0.07 | -0.13 | -2.44 |
| EPS Basic Continuous Ops | 0.18 | 0.32 | 0.07 | -0.13 | -2.44 |
| EPS Diluted Total Ops | 0.18 | 0.30 | 0.07 | -0.13 | -2.44 |
| EPS Diluted Continuous Ops | 0.18 | 0.32 | 0.07 | -0.13 | -2.44 |
| EBITDA(a) | $16,493 | $28,241 | $16,495 | $2,858 | $-103,532 |